Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic

Authors: Maeda, Y.;

Dunlop, Malcolm G.;

Din, Farhat V.N.

Source: BJS

Full text

: https://doi.org/10.1002/bjs.11798

Abstract

COVID-19 has imposed unprecedented healthcare challenges with immediate pandemic-focussed resource mobilization. Severe curtailment of surgical and diagnostic services, including bowel screening, will inevitably lead to delayed diagnosis and treatment of colorectal cancer. There will be an increase in presentation with complications in the medium-term and more advanced stage in the longer-term.

Rights

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Cite as

Maeda, Y., Dunlop, M. & Din, F. 2020, 'Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic', BJS, 107(10), pp. e361-e362. https://doi.org/10.1002/bjs.11798

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1002/bjs.11798

Repository URI: https://eprints.gla.ac.uk/297500/